FMR LLC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:24 am Sale | 2025-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 4,646,943 8.000% | -467,426 (-9.14%) | Filing |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 5,114,369 9.067% | -114,701 (-2.19%) | Filing |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 5,229,070 9.271% | -126,873 (-2.37%) | Filing |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 5,355,943 9.496% | -19,180 (-0.36%) | Filing |